These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cutting Edge: Nonobese Diabetic Mice Deficient in Chromogranin A Are Protected from Autoimmune Diabetes. Baker RL; Bradley B; Wiles TA; Lindsay RS; Barbour G; Delong T; Friedman RS; Haskins K J Immunol; 2016 Jan; 196(1):39-43. PubMed ID: 26608914 [TBL] [Abstract][Full Text] [Related]
3. Detection of vasostatin-1-specific CD8(+) T cells in non-obese diabetic mice that contribute to diabetes pathogenesis. Nikoopour E; Krougly O; Lee-Chan E; Haeryfar SM; Singh B Clin Exp Immunol; 2016 Sep; 185(3):292-300. PubMed ID: 27185276 [TBL] [Abstract][Full Text] [Related]
4. Nanoparticles Containing an Insulin-ChgA Hybrid Peptide Protect from Transfer of Autoimmune Diabetes by Shifting the Balance between Effector T Cells and Regulatory T Cells. Jamison BL; Neef T; Goodspeed A; Bradley B; Baker RL; Miller SD; Haskins K J Immunol; 2019 Jul; 203(1):48-57. PubMed ID: 31109955 [TBL] [Abstract][Full Text] [Related]
5. Regulatory T Cells Induced by Single-Peptide Liposome Immunotherapy Suppress Islet-Specific T Cell Responses to Multiple Antigens and Protect from Autoimmune Diabetes. Bergot AS; Buckle I; Cikaluru S; Naranjo JL; Wright CM; Zheng G; Talekar M; Hamilton-Williams EE; Thomas R J Immunol; 2020 Apr; 204(7):1787-1797. PubMed ID: 32111734 [TBL] [Abstract][Full Text] [Related]
6. Characterization of Human CD4 T Cells Specific for a C-Peptide/C-Peptide Hybrid Insulin Peptide. Wiles TA; Hohenstein A; Landry LG; Dang M; Powell R; Guyer P; James EA; Nakayama M; Haskins K; Delong T; Baker RL Front Immunol; 2021; 12():668680. PubMed ID: 34113344 [TBL] [Abstract][Full Text] [Related]
7. Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4high expression as a marker. Lejon K; Fathman CG J Immunol; 1999 Nov; 163(10):5708-14. PubMed ID: 10553102 [TBL] [Abstract][Full Text] [Related]
8. CD4 T Cells Reactive to Hybrid Insulin Peptides Are Indicators of Disease Activity in the NOD Mouse. Baker RL; Jamison BL; Wiles TA; Lindsay RS; Barbour G; Bradley B; Delong T; Friedman RS; Nakayama M; Haskins K Diabetes; 2018 Sep; 67(9):1836-1846. PubMed ID: 29976617 [TBL] [Abstract][Full Text] [Related]
9. Low TCR signal strength induces combined expansion of Th2 and regulatory T cell populations that protect mice from the development of type 1 diabetes. Turner MS; Isse K; Fischer DK; Turnquist HR; Morel PA Diabetologia; 2014 Jul; 57(7):1428-36. PubMed ID: 24737163 [TBL] [Abstract][Full Text] [Related]
10. Resident macrophages of pancreatic islets have a seminal role in the initiation of autoimmune diabetes of NOD mice. Carrero JA; McCarthy DP; Ferris ST; Wan X; Hu H; Zinselmeyer BH; Vomund AN; Unanue ER Proc Natl Acad Sci U S A; 2017 Nov; 114(48):E10418-E10427. PubMed ID: 29133420 [TBL] [Abstract][Full Text] [Related]
11. Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usage. Diz R; Garland A; Vincent BG; Johnson MC; Spidale N; Wang B; Tisch R PLoS One; 2012; 7(12):e52054. PubMed ID: 23251685 [TBL] [Abstract][Full Text] [Related]
12. Vasostatin-1 antigenic epitope mapping for induction of cellular and humoral immune responses to chromogranin A autoantigen in NOD mice. Nikoopour E; Cheung R; Bellemore S; Krougly O; Lee-Chan E; Stridsberg M; Singh B Eur J Immunol; 2014 Apr; 44(4):1170-80. PubMed ID: 24443235 [TBL] [Abstract][Full Text] [Related]
13. An insulin-IAPP hybrid peptide is an endogenous antigen for CD4 T cells in the non-obese diabetic mouse. Wiles TA; Delong T; Baker RL; Bradley B; Barbour G; Powell RL; Reisdorph N; Haskins K J Autoimmun; 2017 Mar; 78():11-18. PubMed ID: 27802879 [TBL] [Abstract][Full Text] [Related]
14. A Hybrid Insulin Epitope Maintains High 2D Affinity for Diabetogenic T Cells in the Periphery. Liu B; Hood JD; Kolawole EM; Woodruff DM; Vignali DA; Bettini M; Evavold BD Diabetes; 2020 Mar; 69(3):381-391. PubMed ID: 31806623 [TBL] [Abstract][Full Text] [Related]
15. T-bet-deficient NOD mice are protected from diabetes due to defects in both T cell and innate immune system function. Esensten JH; Lee MR; Glimcher LH; Bluestone JA J Immunol; 2009 Jul; 183(1):75-82. PubMed ID: 19535634 [TBL] [Abstract][Full Text] [Related]
16. Antigen presentation events during the initiation of autoimmune diabetes in the NOD mouse. Ferris ST; Carrero JA; Unanue ER J Autoimmun; 2016 Jul; 71():19-25. PubMed ID: 27021276 [TBL] [Abstract][Full Text] [Related]
17. Identifying New Hybrid Insulin Peptides (HIPs) in Type 1 Diabetes. Mannering SI; Rubin AF; Wang R; Bhattacharjee P Front Immunol; 2021; 12():667870. PubMed ID: 33995402 [TBL] [Abstract][Full Text] [Related]
18. Distinct Phenotypes of Islet Antigen-Specific CD4+ T Cells Among the 3 Subtypes of Type 1 Diabetes. Chujo D; Kawabe A; Matsushita M; Takahashi N; Tsutsumi C; Haseda F; Imagawa A; Hanafusa T; Ueki K; Kajio H; Yagi K; Tobe K; Shimoda M J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32652026 [TBL] [Abstract][Full Text] [Related]
19. The role of islet antigen presenting cells and the presentation of insulin in the initiation of autoimmune diabetes in the NOD mouse. Unanue ER; Ferris ST; Carrero JA Immunol Rev; 2016 Jul; 272(1):183-201. PubMed ID: 27319351 [TBL] [Abstract][Full Text] [Related]
20. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct. Li L; He Q; Garland A; Yi Z; Aybar LT; Kepler TB; Frelinger JA; Wang B; Tisch R J Immunol; 2009 Dec; 183(11):7585-91. PubMed ID: 19917704 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]